Works matching DE "MULTIPLE myeloma"

Results: 5000
    1

    Integrative analysis of bulk and single-cell gene expression profiles to identify bone marrow mesenchymal cell heterogeneity and prognostic significance in multiple myeloma.

    Published in:
    Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06637-6
    By:
    • Ju, Fei-Er;
    • Huang, Bei-Hui;
    • Wu, Hao;
    • Zou, Bo;
    • Chen, Shu-Na;
    • Sang, Xiao-Yan;
    • Liang, Wei-Yao;
    • Liu, Zi-Xuan;
    • Zhang, Zi-Xuan;
    • Yang, Zi-Yi;
    • Liang, Yan-Ting;
    • Liang, Yue-Lan;
    • Liu, Huan;
    • Dong, Zhao-Xia;
    • Liu, Xue-Qi;
    • Zheng, Li-Yuan;
    • Zeng, Jin-Cheng;
    • Wang, Jin-Heng;
    • Qi, Lin;
    • Zhang, Xing-Ding
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Multiple Myeloma Unpacked.

    Published in:
    Hematological Oncology, 2025, v. 43, p. 1, doi. 10.1002/hon.70067
    By:
    • Gay, Francesca;
    • Marchetti, Edoardo;
    • Bertuglia, Giuseppe
    Publication type:
    Article
    12
    13
    14

    Jornada do Paciente com Mieloma Múltiplo no Brasil: Um Estudo Descritivo.

    Published in:
    Saúde Coletiva, 2025, v. 15, n. 95, p. 15694, doi. 10.36489/saudecoletiva.2025v15i95p15694-15711
    By:
    • Gomes dos Santos, Ana Carolina;
    • Machado de Almeida, Ana Beatriz;
    • dos Santos Simão, Fernanda Cristina;
    • Melo, Nina;
    • Rosenburg Gioseffi, Janaína;
    • Augusto Fedozzi, Fábio;
    • Fonseca Pinto, Catherine Moura;
    • Hamerschlak, Nelson
    Publication type:
    Article
    15
    16
    17
    18
    19

    Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 6, p. 1020, doi. 10.1111/ejh.14410
    By:
    • Abuhelwa, Ahmad Y.;
    • Almansour, Sara A.;
    • Basch, Ethan;
    • Al‐Shamsi, Humaid O.;
    • Abuhelwa, Ziad;
    • Bustanji, Yasser;
    • Semreen, Mohammad H.;
    • Kharaba, Zelal;
    • Ali, Salma M.;
    • Mohamed, Rawan;
    • Kichenadasse, Ganessan;
    • McKinnon, Ross A.;
    • Sorich, Michael J.;
    • Alzoubi, Karem H.;
    • Hopkins, Ashley M.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Toxicity of CAR T-Cell Therapy for Multiple Myeloma.

    Published in:
    Acta Haematologica, 2025, v. 148, n. 3, p. 300, doi. 10.1159/000539134
    By:
    • Afrough, Aimaz;
    • Abraham, Pearl Rajan;
    • Turer, Laura;
    • Kaur, Gurbakhash;
    • Sannareddy, Aishwarya;
    • Hansen, Doris K.;
    • Anderson Jr., Larry D.
    Publication type:
    Article
    33
    34
    35
    36
    37

    Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 16, doi. 10.1111/ejh.14413
    By:
    • Morabito, Fortunato;
    • Martino, Enrica Antonia;
    • Galli, Monica;
    • Offidani, Massimo;
    • Zambello, Renato;
    • Bringhen, Sara;
    • Giuliani, Nicola;
    • Califano, Catello;
    • Brunori, Marino;
    • Gagliardi, Alfredo;
    • Sgherza, Nicola;
    • Quinto, Angela Maria;
    • Barilà, Gregorio;
    • Belotti, Angelo;
    • Cerchione, Claudio;
    • Casaluci, Gloria Margiotta;
    • Fontana, Raffaele;
    • Bongarzoni, Velia;
    • Tarantini, Giuseppe;
    • Derudas, Daniele
    Publication type:
    Article
    38
    39
    40

    Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 5, p. 1366, doi. 10.1111/bjh.19978
    By:
    • Touzeau, Cyrille;
    • Leleu, Xavier;
    • Tiab, Mourad;
    • Macro, Margaret;
    • Perrot, Aurore;
    • Gay, Julie;
    • Chateleix, Carine;
    • Moreau, Stéphane;
    • Karlin, Lionel;
    • Jacquet, Caroline;
    • Manier, Salomon;
    • Hulin, Cyrille;
    • Decaux, Olivier;
    • Richez, Valentine;
    • Chalopin, Thomas;
    • Mohty, Mohamad;
    • Orsini‐Piocelle, Frédérique;
    • Caillot, Denis;
    • Sonntag, Cécile;
    • Vignon, Marguerite
    Publication type:
    Article
    41
    42
    43
    44
    45

    Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7
    By:
    • Encinas, Cristina;
    • Lozano, Virginia;
    • Hlavacek, Patrick;
    • Llinares, Julia;
    • Toribio-Castelló, Sofía;
    • Carcedo, David;
    • Asís-Montalt, Jordi;
    • Martínez-López, Joaquín
    Publication type:
    Article
    46
    47
    48

    Predicting progression events in multiple myeloma from routine blood work.

    Published in:
    NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01636-9
    By:
    • Ferle, Maximilian;
    • Grieb, Nora;
    • Kreuz, Markus;
    • Ader, Jonas;
    • Goldschmidt, Hartmut;
    • Mai, Elias K.;
    • Bertsch, Uta;
    • Platzbecker, Uwe;
    • Neumuth, Thomas;
    • Reiche, Kristin;
    • Oeser, Alexander;
    • Merz, Maximilian
    Publication type:
    Article
    49
    50